Regulations.gov document
Patent Extension Application from Alston & Bird LLP (on behalf of Ascendis Pharma Bone…
Other · FDA-2024-E-5100 · posted Nov 8, 2024
Key facts
| Document ID | FDA-2024-E-5100-0002 |
|---|---|
| Title | Patent Extension Application from Alston & Bird LLP (on behalf of Ascendis Pharma Bone Diseases A/S) |
| Document type | Other |
| Subtype | Application |
| Agency | FDA |
| Docket | FDA-2024-E-5100 |
| Posted | Nov 8, 2024 |
| Comment period opens | Nov 8, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: